Research Highlight | Published:

HYPERTENSION

Renewed hopes for renal denervation in hypertension

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original articles

    1. Kandzari, D. E. et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet https://doi.org/10.1016/S0140-6736(18)30951-6 (2018)

    2. Azizi, M. et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet https://doi.org/10.1016/S0140-6736(18)31082-1 (2018)

    Further reading

    1. Gulati, R. et al. The rise, fall, and possible resurrection of renal denervation. Nat. Rev. Cardiol. 13, 238–244 (2016)

    Download references

    Author information

    Correspondence to Irene Fernández-Ruiz.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark